Study Name: Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
28 locations found
- XenoPort Clinical Site
Location: Phoenix, Arizona
- XenoPort Clinical Site
Location: Tucson, Arizona
- XenoPort Clinical Site
Location: Berkeley, California
- XenoPort Clinical Site
Location: San Diego, California
- XenoPort Clinical Site
Location: Denver, Colorado
- XenoPort Clinical Site
Location: Port Charlotte, Florida
- XenoPort Clinical Site
Location: Sarasota, Florida
- XenoPort Clinical Site
Location: St. Petersburg, Florida
- XenoPort Clinical Site
Location: Tampa, Florida
- XenoPort Clinical Site
Location: Lake Barrington, Illinois
- XenoPort Clinical Site
Location: Indianapolis, Indiana
- XenoPort Clinical Site
Location: Lenexa, Kansas
- XenoPort Clinical Site
Location: Lexington, Kentucky
- XenoPort Clinical Site
Location: Bingham Farms, Michigan
- XenoPort Clinical Site
Location: Detroit, Michigan
- XenoPort Clinical Site
Location: Toms River, New Jersey
- XenoPort Clinical Site
Location: Albuquerque, New Mexico
- XenoPort Clinical Site
Location: Albany, New York
- XenoPort Clinical Site
Location: Patchogue, New York
- XenoPort Clinical Site
Location: Plainview, New York
- XenoPort Clinical Site
Location: Asheville, North Carolina
- XenoPort Clinical Site
Location: Akron, Ohio
- XenoPort Clinical Site
Location: Franklin, Tennessee
- XenoPort Clinical Site
Location: Nashville, Tennessee
- XenoPort Clinical Site
Location: San Antonio, Texas
- XenoPort Clinical Site
Location: Vienna, Virginia
- XenoPort Clinical Site
Location: Seattle, Washington
- XenoPort Clinical Site
Location: Tacoma, Washington
|